The Winning Formula
for Champions
There are no known contraindications to the use of intramuscular Adequan
®
i.m. brand Polysulfated Glycosaminoglycan in horses. Studies have not been conducted to establish safety in
breeding horses. WARNING: Do not use in horses intended for human consumption. Not for use in humans. Keep this and all medications out of the reach of children. Caution: Federal law
restricts this drug to use by or on the order of a licensed veterinarian. Each 5 mL contains 500 mg Polysulfated Glycosaminoglycan. Brief Summary Indications: For the intramuscular treatment
of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses.
SEE PRODUCT PACKAGE INSERT FOR FULL PRESCRIBING INFORMATION.
Adequan
®
is a registered trademark of Luitpold Pharmaceuticals, Inc. ©LUITPOLD PHARMACEUTICALS, INC., Animal Health Division, 2014
Shirley, NY 11967. Image of Adrienne Lyle and Wizard ©Susan J. Stickle is used with permission. AHD025, Iss. 5/2014
Adrienne Lyle and Wizard placed first in the
FEI Grand Prix CDI 5* Presented by Diamante Farms
at the 2014 Adequan
®
Global Dressage Festival
Adequan
®
IM (polysulfated glycosaminoglycan) is the only product approved by the FDA for the treatment of non-infectious degenerative
and/or traumatic joint dysfunction and associated lameness in horses. To learn more, visit www.nogenericadequan.com
